Skip to main content
OpenTrials
Completed

NCT Number: NCT07613229

Evaluation of Cardiovascular Risks Among the Participants of the ESC Congress 2025

The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens. In line with this call for public health diagnosis of CV health, the ESC is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Congress 2025 in Madrid.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Risk

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Evidenze Health España S.L.U.

Madrid, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All healthcare professionals (doctors, nurses, etc.) attending the ESC Congress 2025 from August 29th to September 1st
  • Subjects who declare that they are able to understand and give IC in English

Exclusion criteria

  • Subjects not willing to provide his/her consent to participate in the study.
  • Subjects who are not suitable candidates for blood extraction.

Treatment and study plan

Questionnaire and Physical Exam

Behavioral

Questionnaire about demographics information, medical history and current CV medication.

Blood Draw

Biological

Blood draw

auscultation

Procedure

Auscultation procedure to measure the presence or absence of cardiac murmur and normal or abnormal heart sounds

Primary outcomes

  1. Systemic Coronary Risk Evaluation 2 (SCORE2) algorithm in patients without established CVD (primary prevention).

    Time frame: At baseline

  2. Second Manifestations or Arterial Disease (SMART) algorithm in patients with established CVD (secondary prevention)

    Time frame: At baseline

Sponsors and collaborators

Lead sponsor

European Society of Cardiology

Network

Registry information

Official study title

Cross-Sectional Assessment of Cardiovascular Risk Among ESC Congress 2025 Participants

Acronym: ESC-CVRISK2025

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
May 29, 2026
Registry last updated
May 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.